EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Partnerships
Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training
Psychedelic Medicine
May 21, 2024
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Psychedelic Medicine

Psychedelic Medicine

View industry hub
May 21, 2024

Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training

Partnerships

  • Fluence, a company specializing in psychedelic therapy training, has partnered with Metamorph AI, a technology company, to develop a GenAI tool for psychedelic therapy training.

  • The tool analyzes therapist role-play sessions, identifies areas for improvement, and provides actionable feedback by highlighting missed therapeutic opportunities, flagging deeper engagement possibilities, and generating self-assessment reports. It's integrated into Fluence’s training program to boost training efficiency, and therapy effectiveness while reducing review time for instructors.

  • Analyst QuickTake: Fluence has established several partnerships within the psychedelic industry, including Reunion Neuroscience (April 2024), Psyence (April 2024), Cybin (September 2023), and Tryp Therapeutics (May 2021). The latest partnership with Metamorph AI is expected to enhance the landscape of psychedelic therapy training.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.